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.Summary Smoking has contributed to various neurological, cardiovascular, and
pulmonary diseases. According to carcinogens found in cigarette smog, benzene is
one of the important carcinogenic compounds. The urinary trans, trans-muconic acid
(ttMA) levels among a sample of 10 Thai smokers and 35 Thai non-smokers were
investigated, compared and reported. The average urinary ttMA level in smokers and
non-smokers were 2.1972.32 and 0.2470.33mg/gCr, respectively. A significant
higher urinary ttMA level among the smokers was observed (Po0:05). Since the
higher urinary ttMA indicates the higher occult risk for cancer, the usage of urinary
ttMA is recommended as a monitoring tool to follow up benzene exposure in the
smokers.
& 2004 Elsevier Ltd. All rights reserved.Introduction
Tobacco smoking is a reprehensible habit that
spreads all over the world as an epidemic.1,2 Life
expectancy of smokers is reduced. In addition,
smoking increases overall medical costs and con-
tributes to the loss of productivity during the life
span. Smoking has contributed to various neurolo-Elsevier Ltd. All rights reserv
48832; fax: +662 2183771.
tserv.chula.ac.thgical, cardiovascular, and pulmonary diseases.
Cigarette smoke contains several carcinogens that
can alter biochemical defense systems and lead to
lung cancer.1,2 According to carcinogens found in
cigarette smog, benzene is one of important
carcinogenic compounds.3
Benzene is a volatile carcinogen and can cause
serious health problem.4 Immediate effects of high
inhalation exposure include headache, tiredness,
nausea and dizziness.4 Unconsciousness may occur
if exposure is very high.4 Recent research indicates
that benzene exposure can result in chronic toxicityed.
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toxicity.4 Several international organizations in-
cluding Agency for Toxic Substances and Disease
Registry (ATSDR)5 document for benzene toxicity. In
exposure- and risk-evaluation, monitoring of ben-
zene by peripheral biomarker has several advan-
tages over other technical assessments of
exposure. For this purpose, several biomarkers for
benzene have been proposed. Of those biomarkers,
the urine trans, trans-muconic acid (ttMA) level is
accepted as a useful monitoring tool for early
diagnosis of dangerous exposure.6,7
At present, there are some studies on the
monitoring for urinary ttMA among the risk workers.
However, there is no report on urinary ttMA as a
biomarker for benzene exposure from smoking.
Here, the authors investigated the urine levels
among a sample of Thai subjects. The comparison
between smokers and non-smokers were performed
and reported.Materials and methods
Subjects
Forty-five healthy volunteer Thai male subjects
were included in this study. They were Thai officers
from the same office in an urban area, namely
Pathumwon District, Bangkok. The dosage of
environmental benzene exposure in these subjects
was 0.15mg/m3 (ambient air sampling by Mini
Pump SKC 224 PCK R8, gravimetric analytical
method NIOSH). All subjects were healthy adults
and had same eating and drinking habits. Before
the study, all were interviewed for possible
occupational exposure to benzene. Also, they
were asked for history of smoking. In cases that
the subjects had any history of smoking, both
active and passive, they are classified as smokers.
The sample size in this study was derived from
the calculation based on our previous study. The
Faculty of Medicine and Faculty of Allied Health
Sciences, Chulalongkorn University, approved the
study. After obtaining informed consent, each
subject provided a urine sample for laboratory
analysis.
Analysis for the urinary ttMA level
All collected samples in this study were sent to the
laboratory for further analysis for ttMA level.
Determination of ttMA level was performed using
high-performance liquid chromatography method
as described in our recent previous study.8 Briefly,0.5mL of urine sample was mixed with 2mL of Tris
Buffer containing vanillic acid as internal standard
(IS).8 Then this mixture was percolated through a
preconditioned ion-exchange column. After rinsing
the column with phosphoric acid solution, acetate
buffer, and deionized water, we eluated the
analytes with 2mL of an equivolume solution of
1.5mol/L sodium chloride and methanol. Of this,
100 mL is injected into the HPLC column.8 The
mobile phase used consisted of, per liter, 10mL of
acetic acid, 100mL of methanol, and 5mmol/L
sodium acetate. The flow rate was started at
1.2mL/min.8 The ttMA and IS were detected at
4.2–4.4 and 12.6–13.3min, respectively.8 To calcu-
late the quantity of ttMA, standard curve was
performed.8 The ttMA results are expressed as mg/
gCr. The lowest detection limit (sensitivity) was
0.025mg/L. The recovery ranged from 91.12 to
93.36%.8 From precision study, % CV was equal to
3.2%.
Statistical analysis
Data were collected for statistical analysis using
SPSS 7.0 for Windows Program. Unpaired t-Test was
used for comparison of the value of ttMA acids. In
addition, regression analysis was performed to
assess the correlation between the number of
cigarette smoked and urinary ttMA level. A statis-
tical significant level was accepted at P-value equal
to or less than 0.05.Results
A total of 45 subjects (all males), 10 smokers and 35
non-smokers, were included into this study. The
average urinary ttMA level in smokers and non-
smokers are 2.1972.32 (range 0–7.08) and
0.2470.33 (range: 0–0.98)mg/gCr, respectively. A
significant higher urinary ttMA level among the
smokers was observed (Po0:05; Table 1). Concern-
ing the regression analysis, the comparison-of-
methods plot number of cigarettes smoked (X) vs.
urinary ttMA level (Y) gave the least square linear
regression equation of Y ¼ 0:2X  1:99 (r ¼ 0:798;
Po0:01); (Fig. 1).Discussion
Over 3800 compounds can be found in tobacco
smoke, many of which are known as carcinogens.2
Most toxic substance exposure is from sidestream
smoke emitted from the burning tip of the
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Figure 1 Scatterplot showing the correlation between
number of cigarettes smoked (X) vs. urinary ttMA
level (Y).
Table 1 Urinary ttMA level smokers and non-smokers.
Group Number of subjects Urinary ttMA (mg/gCr)
Mean SD Maximum Minimum
Smokers 10 2.19 2.32 7.08 0
Non-smokers 35 0.24 0.33 0.98 0
V. Wiwanitkit et al.790cigarette.2 Sidestream smoke is hazardous because
it contains high concentrations of ammonia, ben-
zene, nicotine, carbon monoxide, and many carci-
nogens.2 According to the study of Darrall et al.,3
smoking cigarettes gives an average yield of 50 mm
of benzene per cigarette. This value is considerably
high compared with the occupational maximum
exposure limit (16mg/m3) concentration.3
Assessment of urinary ttMA as a biomarker of
exposure to benzene is an interesting topic at
present.9 There are some reports that heavy
smokers have high urinary ttMA level.10 According
to a recent study on tobacco-smoke exposure
indicators and mutagenicity by Pavanello et al.,
the influence of urinary 1-pyrenol on urinary
mutagenicity was predominant, followed by those
of urinary ttMA and nicotine plus metabolites.11
Here, the authors report the feasibility in using
benzene biomarkers for monitoring of benzene
exposure in general healthy population. A group
of Thai officers in an office with the same level of
environmental benzene were selected and divided
into smoker and non-smoker groups.
Here, we found a significant higher level of
urinary ttMA among smokers than non-smokers. The
mean urinary ttMA is 9.1 times more in smoker thannon-smokers. In other studies published about
urinary ttMA in smokers, the ratio of the urinary
ttMa levels between smokers and non-smokers
ranged from 1.4 to 1.8.12,13 The additional amount
of ttMA level excreted by smokers ranged from
0.022 to 0.2 (mean: 0.1)mg/gCr.12,13 Since the
subjects in this study were well selected from the
same workplace with the same environmental
benzene exposure level, better controlling for
environmental variation, the findings should be a
more valid contribution.
Of interest, although the smokers had higher
urinary ttMA, implying higher benzene accumula-
tion, they had no gross abnormality. Therefore, the
urinary ttMA can be an early marker for benzene
exposure from smoking. Although there are some
studies reporting the influence of smoking on
increase urinary ttMA10,14 there is no application
for usage as biomarker for smoking. Since the
higher urinary ttMA indicates the higher occult risk
for cancer,15 the usage of urinary ttMA is recom-
mended as a monitoring tool to follow up benzene
exposure in the smokers. Specific preventive
actions including smoking cessation and prevention
for smokers with high urinary ttMA is recom-
mended. Also, urinary ttMA might be useful marker
for follow up of compliance of patients on tobacco
cessation period.
Some limitations of this study should be men-
tioned. First, the authors tried to collect the
subjects from the same workplace with the same
environmental benzene exposure level. The total
number of smokers in this study is rather small. A
further larger study is recommended. Secondly,
the detection limit of the analytical method of
our study, 0.025mg/L, is slightly high comparing to
the lowest level reported by Valente et al.
(0.010mg/L).10 Further investigation with more
advanced method which can help increase the
detection limit is recommended.References
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